PMDD Supplements: What the Research Supports — and What It Doesn’t

Which supplements for PMDD have evidence behind them

A small number of supplements for PMDD have credible randomized-trial support: calcium, vitamin B6, and chasteberry. Magnesium and omega-3 show promise on thinner evidence. Everything else commonly recommended online rests on tradition or a single small study. None of them replaces an evaluation, and most were studied in women with PMS.

PMDD, or premenstrual dysphoric disorder, is a mood disorder tied to the luteal phase, the stretch between ovulation and your period. Roughly 2 to 5 percent of women meet its criteria, per ACOG’s clinical practice guideline. Our PMDD page covers what it is and how it is diagnosed. Still weighing whether this is PMDD or ordinary PMS? Start with how PMDD differs from PMS.

How we grade supplement evidence for PMDD

Supplement research is weaker than drug research, and knowing why helps you make sense of the grades below. A randomized controlled trial assigns people to the supplement or to a dummy pill by chance, so the groups differ only in what they took. That is the bar used here, and supplement trials often struggle to clear it. They tend to be small, and they frequently test different preparations of the same plant.

The rules are looser too. FDA does not approve supplements for safety or effectiveness before they go on sale, and manufacturers carry that responsibility instead. A 2025 systematic review pooled 31 randomized trials in 3,254 women and judged exactly one of the 31 well enough designed to trust its result.

Most of this research also enrolled women with PMS, not women whose PMDD was confirmed by daily symptom tracking. It is borrowed evidence, and we say so where it applies. We rank the same way across all our writing on supplements: randomized placebo-controlled evidence first, small uncontrolled studies second, tradition last. That method is set out in how we grade supplement evidence.

Calcium, vitamin B6, and chasteberry have the strongest support

Calcium has the cleanest trial behind it. In the largest placebo-controlled study, 466 women tracked symptoms across three cycles, and total scores fell 48 percent on calcium against 30 percent on placebo. The gap over placebo is the honest number, and it is modest. Calcium is one of the minerals the body uses for nerve transmission and muscle function, per NIH’s Office of Dietary Supplements, which is the usual starting point for why it might steady premenstrual symptoms. ACOG suggests calcium while labeling the evidence low quality. High intake has been linked to kidney stones, so count what food already gives you.

Vitamin B6 comes next. A systematic review of nine placebo-controlled trials in 940 women found it better than placebo for premenstrual symptoms and for premenstrual depression, and its authors said most of those trials were low quality. B6 is a coenzyme the body uses to build neurotransmitters, per NIH, so a mood effect is plausible. It is also our standing example that natural does not mean safe. Sustained high intake causes progressive sensory neuropathy, nerve damage felt as numbness and unsteadiness, and NIH sets an upper intake limit because of it.

Regulators disagree about where that limit belongs. Europe’s food safety authority cut its adult limit sharply in 2023, naming nerve damage as the deciding harm, and Australia now requires a warning telling people to stop at the first tingling or numbness. Reported cases involve long use as much as large amounts, and the American limit is lower for teenagers than for adults. Treat B6 as time-limited and prescriber-supervised.

Chasteberry for PMDD

Chasteberry for PMDD has the largest trial base of any herb here and the shakiest quality control. A meta-analysis found 13 of 14 placebo-controlled trials positive. The same analysis found those trials disagreed with each other sharply and showed signs that studies finding no benefit went unpublished, so the reported benefit deserves caution.

That disagreement between trials was measured at 91 percent, about as high as it goes. Compounds in chasteberry (Vitex agnus-castus) act on the pituitary gland in the brain and lower the hormone prolactin, per NIH’s lactation database. One randomized trial has run in women with diagnosed PMDD: chasteberry and fluoxetine helped about the same share of women, but fluoxetine did more for psychological symptoms while chasteberry did more for physical ones. That trial had 41 participants and no placebo group, and only the staff scoring symptoms were kept unaware of who took what, so it cannot show the two work equally well. Mood defines PMDD, and mood is where chasteberry did less. ACOG reviewed the same literature and concluded that further study is needed. NCCIH advises skipping chasteberry if you have a hormone-sensitive condition, and NIH’s LiverTox database advises against it for anyone on hormonal birth control or hormone replacement.

One tier down, magnesium and omega-3

Both are reasonable to raise with a prescriber. Neither is proven the way the tier above is.

Magnesium for PMDD

Magnesium for PMDD has mixed evidence. Small trials point in different directions, and results seem to depend on which chemical form was used: an earlier systematic review found benefit for magnesium pyrrolidone and none for magnesium oxide. The most recent review put magnesium in its insufficient-evidence group.

Every magnesium trial in this area enrolled fewer than 50 women, small enough that a modest true effect and no effect look alike. NIH describes magnesium as a cofactor in enzyme systems that regulate muscle and nerve function, so the rationale is sound. The practical catch is side effects. Higher intake causes diarrhea, and oxide and carbonate are common culprits while citrate and lactate absorb more completely.

Omega-3 for PMDD

Pooled trials favor omega-3 for premenstrual symptoms, with a stronger effect on physical symptoms than on mood, and they disagree with one another about as much as the chasteberry trials do. NIH describes omega-3s as building blocks of cell membranes, with DHA especially concentrated in the brain, which is the usual basis for expecting a mood effect. Omega-3 is familiar and generally well tolerated, which is why we treat it as a low-risk option worth raising.

Where saffron, St John’s wort, and the rest land

Eight more supplements turn up on PMDD lists. None earns a place above this tier, and the reason differs item by item.

Herbs for PMDD

Herbs for PMDD have one genuine exception and a lot of tradition. Chasteberry earned the top tier. Saffron rests on a single small placebo-controlled trial with no independent replication. St John’s wort helped physical symptoms and left mood unchanged, and it interacts with SSRIs. Nothing else here has controlled evidence.

Saffron: one double-blind placebo-controlled trial reported benefit over two cycles, and no independent team has repeated it.

St John’s wort: the one randomized trial for premenstrual symptoms improved physical and behavioral symptoms and did nothing significant for mood. The interactions covered below make it a poor choice anyway.

Kami-shoyo-san: the study people cite gave the herb to 30 patients with no comparison group, and everyone knew what they were taking, so its result cannot be separated from placebo. A Cochrane review of Chinese herbal medicine for premenstrual syndrome found insufficient evidence.

Vitamin D, zinc, and myo-inositol for PMDD

Vitamin D: the reviews disagree. A meta-analysis of five trials found lower overall severity while rating its own certainty very low, and the 31-trial review called the evidence insufficient. The clearest positive trial enrolled only women who were already low in vitamin D, which makes this a case for correcting a deficiency.

Zinc: one randomized placebo-controlled trial in 69 students reported broad improvement, and the 31-trial review lists zinc among the nutrients with consistent effects. One trial is not enough to move zinc up a tier.

Myo-inositol: the only randomized trial in diagnosed PMDD found no benefit over placebo. With 11 participants, that leaves the question open rather than settled against it.

Proprietary blends: no blend sold for PMDD has been tested against placebo. A mixture of studied ingredients is not a studied product. Chamomile appears on these lists too, with no controlled premenstrual evidence either way.

The safety checks a prescriber runs on PMDD supplements

Bring your full supplement list to every appointment, including the bottles you assume do not count. Supplements are part of the medication picture, and several items above carry specific problems.

St John’s wort is the one we flag hardest. FDA-approved SSRI labeling names it among the substances that raise serotonin and, with it, the risk of serotonin syndrome (too much serotonin activity, which can cause agitation and fever). FDA also classifies St John’s wort as a strong CYP3A inducer, meaning it makes the body clear other medicines faster, and controlled studies found it lowered oral contraceptive hormone levels, raised breakthrough bleeding, and allowed the ovaries to start developing eggs. Someone with PMDD is often taking an SSRI, hormonal birth control, or both.

St John’s wort is not the only supplement that adds serotonin. The same FDA labeling names L-tryptophan, NCCIH says SAM-e may interact with drugs that raise serotonin, and 5-HTP is a direct serotonin precursor. NCCIH also warns that SAM-e can worsen mania, which makes it a poor choice for anyone with bipolar disorder.

The upper limit on vitamin B6 is the other one to keep in mind, and the NIH limit counts food and supplements together. Chasteberry carries hormonal cautions and is not established as safe in pregnancy or while breastfeeding.

Take this list to your prescriber and ask about each line that applies to you:

• St John’s wort, alongside any SSRI, SNRI, or hormonal birth control
• Anything sold for mood, including L-tryptophan, SAM-e, and 5-HTP
• Vitamin B6, if you have been taking it for more than a few months
• Chasteberry, if you are pregnant, breastfeeding, or using hormonal contraception
• Any product carrying no independent verification seal

Product quality is a separate problem. What is on the label is not always what is in the bottle, and NCCIH notes that FDA has found prescription drugs hidden inside products sold as supplements. The practical check is a seal from an independent tester such as USP or NSF, which means the product was properly made and holds what the label says without unsafe contaminants. NIH’s Office of Dietary Supplements is blunt that such a seal does not mean the product is safe or that it works.

How to tell whether the supplement is helping your PMDD

One change at a time. Start calcium and magnesium in the same week and you learn nothing about either. Rate your symptoms daily across at least two full cycles before you judge, which is the same prospective tracking used to diagnose PMDD in the first place. Two cycles is not an arbitrary number, since one good month can simply be an ordinary good month.

Tracking also separates PMDD from something else. In PMDD the symptoms clear in the week or two after your period. Symptoms that never fully lift suggest a mood disorder that worsens premenstrually, which ACOG calls premenstrual exacerbation. That difference changes the treatment, so bring the chart to your prescriber.

Set your expectation before you begin. In our practice, the women who respond to a supplement describe symptoms that are a little less sharp. Few describe a cycle that feels normal. Pick your stop point in advance and write it down. Make the final call with your prescriber, at a calm point in the cycle.

When supplements aren’t enough for PMDD

The line is impairment. If your work or your closest relationships are still taking damage after a fair two-cycle trial, that is prescriber territory. The same applies if the luteal weeks keep getting worse.

If you are having thoughts of suicide, do not wait another cycle to get help. Premenstrual suicidal thinking is a recognized feature of PMDD, and a meta-analysis found about twice the odds of suicidal thoughts among people who have it. Call or text 988, the 988 Suicide & Crisis Lifeline, or go to your nearest emergency department.

There is good reason for optimism at this step, and more than one route. ACOG makes three strong recommendations for premenstrual symptoms: SSRIs, combined oral contraceptives, and cognitive behavioral therapy. Three SSRIs carry FDA approval for PMDD, and so does one combined pill on a 24-day schedule, for people already choosing a contraceptive. ACOG cautions that combined pills may not help mood symptoms, so they suit some people and not others.

A 2024 Cochrane review of 34 trials found SSRIs probably reduce premenstrual symptoms. In PMDD, SSRIs can begin working within days rather than the weeks depression usually needs, and they can be taken daily or only during the luteal phase, though that same review found daily use probably works somewhat better. Our medication management page covers how that works.

Questions we hear most

General information, not medical advice for your situation. Nothing here recommends a dose or tells you what to take. Talk with your own prescriber before starting or combining anything.